메뉴 건너뛰기




Volumn 43, Issue 5, 2011, Pages 1928-1933

Basiliximab for the treatment of steroid-refractory acute graft-versus-host disease after unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SEMUSTINE; THYMOCYTE ANTIBODY;

EID: 79959403472     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.03.044     Document Type: Article
Times cited : (36)

References (20)
  • 1
    • 0032558759 scopus 로고    scopus 로고
    • Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with 1 fully mismatched HLA haplotype
    • F. Aversa, A. Tabilio, and A. Velardi Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with 1 fully mismatched HLA haplotype N Engl J Med 339 1998 1186
    • (1998) N Engl J Med , vol.339 , pp. 1186
    • Aversa, F.1    Tabilio, A.2    Velardi, A.3
  • 2
    • 0242559250 scopus 로고    scopus 로고
    • Haploidentical stem cell transplantation for acute leukemia
    • F. Aversa, A. Terenzi, and R. Felicini Haploidentical stem cell transplantation for acute leukemia Int J Hematol 7 suppl 2002 165
    • (2002) Int J Hematol , vol.7 , Issue.SUPPL. , pp. 165
    • Aversa, F.1    Terenzi, A.2    Felicini, R.3
  • 3
    • 11144325816 scopus 로고    scopus 로고
    • Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases
    • F. Aversa, and M.F. Martelli Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases Springer Semin Immunopathol 26 2004 155
    • (2004) Springer Semin Immunopathol , vol.26 , pp. 155
    • Aversa, F.1    Martelli, M.F.2
  • 4
    • 17444376823 scopus 로고    scopus 로고
    • Human leukocyte antigen haploidentical hematopoietic stem cell transplantation; Indications and tentative outcomes in Japan
    • Y. Kodera, T. Nishida, and T. Ichinohe Human leukocyte antigen haploidentical hematopoietic stem cell transplantation; indications and tentative outcomes in Japan Semin Hematol 42 2005 112
    • (2005) Semin Hematol , vol.42 , pp. 112
    • Kodera, Y.1    Nishida, T.2    Ichinohe, T.3
  • 5
    • 33746936705 scopus 로고    scopus 로고
    • Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological disease
    • X.J. Huang, D.H. Liu, and K.Y. Liu Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological disease Bone Marrow Transplant 38 2006 291
    • (2006) Bone Marrow Transplant , vol.38 , pp. 291
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3
  • 6
    • 24944433163 scopus 로고    scopus 로고
    • Efficacy of the interleukin-2 receptor antagonist basiliximab insteroid-refractory acute graft-versus-host disease
    • M. Schmidt-Hieber, T. Fietz, and W. Knauf Efficacy of the interleukin-2 receptor antagonist basiliximab insteroid-refractory acute graft-versus-host disease Br J Haematol 130 2005 568
    • (2005) Br J Haematol , vol.130 , pp. 568
    • Schmidt-Hieber, M.1    Fietz, T.2    Knauf, W.3
  • 7
    • 0036947659 scopus 로고    scopus 로고
    • Basiliximab is well tolerated and effective in the treatment ofsteroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    • G. Massenkeil, S. Rackwitz, and I. Genvresse Basiliximab is well tolerated and effective in the treatment ofsteroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation Bone Marrow Transplant 30 2002 899
    • (2002) Bone Marrow Transplant , vol.30 , pp. 899
    • Massenkeil, G.1    Rackwitz, S.2    Genvresse, I.3
  • 8
    • 34548062133 scopus 로고    scopus 로고
    • Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease
    • M.A. Perales, N. Ishill, and W.A. Lomazow Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease Bone Marrow Transplant 40 2007 481
    • (2007) Bone Marrow Transplant , vol.40 , pp. 481
    • Perales, M.A.1    Ishill, N.2    Lomazow, W.A.3
  • 9
    • 0033964862 scopus 로고    scopus 로고
    • Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
    • D. Przepiorka, N.A. Kernan, and C. Ippoliti Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 95 2000 83
    • (2000) Blood , vol.95 , pp. 83
    • Przepiorka, D.1    Kernan, N.A.2    Ippoliti, C.3
  • 10
    • 33749253337 scopus 로고    scopus 로고
    • Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    • P. Bordigoni, S. Dimicoli, and L. Clement Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease Br J Haematol 135 2006 382
    • (2006) Br J Haematol , vol.135 , pp. 382
    • Bordigoni, P.1    Dimicoli, S.2    Clement, L.3
  • 11
    • 0021296674 scopus 로고
    • Graft-versus-host disease: Pathophysiological and clinical aspects
    • H.J. Deeg, and R. Storb Graft-versus-host disease: pathophysiological and clinical aspects Annu Rev Med 35 1984 11
    • (1984) Annu Rev Med , vol.35 , pp. 11
    • Deeg, H.J.1    Storb, R.2
  • 12
    • 31344470436 scopus 로고    scopus 로고
    • Daclizumab for children with corticosteroid refractory graft-versus-host disease
    • D.T. Teachey, B. Bickert, and N. Bunin Daclizumab for children with corticosteroid refractory graft-versus-host disease Bone Marrow Transplant 37 2006 95
    • (2006) Bone Marrow Transplant , vol.37 , pp. 95
    • Teachey, D.T.1    Bickert, B.2    Bunin, N.3
  • 13
    • 12144288738 scopus 로고    scopus 로고
    • Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis
    • R. Srinivasan, S. Chakrabarti, and T. Walsh Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis Br J Haematol 124 2004 777
    • (2004) Br J Haematol , vol.124 , pp. 777
    • Srinivasan, R.1    Chakrabarti, S.2    Walsh, T.3
  • 14
    • 62549109110 scopus 로고    scopus 로고
    • Daclizumab as useful treatment in refractory acute GVHD: A paediatric experience
    • M. Miano, D. Cuzzubbo, and P. Terranova Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience Bone Marrow Transplant 43 2009 423
    • (2009) Bone Marrow Transplant , vol.43 , pp. 423
    • Miano, M.1    Cuzzubbo, D.2    Terranova, P.3
  • 15
    • 64149091117 scopus 로고    scopus 로고
    • Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease
    • T. Schechter, S. Afzal, and Y. Finkelstein Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease Pediatr Transplant 13 2009 332
    • (2009) Pediatr Transplant , vol.13 , pp. 332
    • Schechter, T.1    Afzal, S.2    Finkelstein, Y.3
  • 16
    • 0035107591 scopus 로고    scopus 로고
    • Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    • W. Willenbacher, N. Basara, and I.W. Blau Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab Br J Haematol 112 2001 820
    • (2001) Br J Haematol , vol.112 , pp. 820
    • Willenbacher, W.1    Basara, N.2    Blau, I.W.3
  • 17
    • 40249100508 scopus 로고    scopus 로고
    • Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: A single centre experience with 12 allograft patients
    • C.H. Hui, H. Sia, and H. Mangos Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients Bone Marrow Transplant 41 2008 409
    • (2008) Bone Marrow Transplant , vol.41 , pp. 409
    • Hui, C.H.1    Sia, H.2    Mangos, H.3
  • 18
    • 39049191830 scopus 로고    scopus 로고
    • Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients
    • L.P. Xu, X.J. Huang, and N.L. Guo Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients Chin J Hematol 24 2003 407
    • (2003) Chin J Hematol , vol.24 , pp. 407
    • Xu, L.P.1    Huang, X.J.2    Guo, N.L.3
  • 19
    • 58249132219 scopus 로고    scopus 로고
    • Treatment of acute leukemia with unmanipulated HLA-mismatched/ haploidentical blood and bone marrow transplantation
    • X.J. Huang, D.H. Liu, and K.Y. Liu Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation Biol Blood Marrow Transplant 15 2009 257
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 257
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3
  • 20
    • 4444304402 scopus 로고    scopus 로고
    • Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: Results of a randomized trial
    • S.J. Lee, D. Zahrieh, and E. Agura Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial Blood 104 2004 1559
    • (2004) Blood , vol.104 , pp. 1559
    • Lee, S.J.1    Zahrieh, D.2    Agura, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.